These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 2822796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR, Thibault G, Kuchel O, Hamet P, Cantin M, Larochelle P.
    J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
    [Abstract] [Full Text] [Related]

  • 3. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM, Strazzulla G, Fabbri G, Piazza E, Valenza T, De Feo ML, Franchi F.
    Ann Ital Med Int; 1991 Apr; 6(3):273-83. PubMed ID: 1837999
    [Abstract] [Full Text] [Related]

  • 4. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE.
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [Abstract] [Full Text] [Related]

  • 5. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW, Canepa-Anson R, Armstrong PW.
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [Abstract] [Full Text] [Related]

  • 6. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J, Genest J, Larochelle P, Cusson J, Gutkowska J, Hamet P, De Léan A, Thibault G, Cantin M.
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [Abstract] [Full Text] [Related]

  • 7. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM, Crozier IG, Espiner EA, Ikram H, Yandle TG, Kosoglou T, Rallings M, Frampton C.
    J Cardiovasc Pharmacol; 1992 Jun; 20(5):735-41. PubMed ID: 1280735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changed cyclic guanosine monophosphate atrial natriuretic factor relationship in hypertensive man.
    Bruun NE, Nielsen MD, Skøtt P, Giese J, Leth A, Schütten HJ, Rasmussen S.
    J Hypertens; 1989 Apr; 7(4):287-91. PubMed ID: 2542401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 12. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J, Duboc D, Weber S, Fouchard J, Schwartz JC, Muffat-Joly M, Guérin F.
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [Abstract] [Full Text] [Related]

  • 13. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 14. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G, Cottone S, Mangano MT, D'Ignoto G, Pinto A, Carone MB.
    Clin Ther; 1988 Jun; 10(6):694-703. PubMed ID: 2975530
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Some physiopathological aspects of atrial natriuretic factor.
    Garcia R, Cantin M, Cusson JR, Genest J, Gutkowska J, Larochelle P, Schiffrin EL, Thibault G.
    J Hypertens Suppl; 1986 Jun; 4(2):S125-9. PubMed ID: 2941534
    [Abstract] [Full Text] [Related]

  • 17. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL, Arendt R, Xie Y, Knorr HJ, Riedel A, Paumgartner G.
    Z Kardiol; 1988 Jun; 77 Suppl 2():99-103. PubMed ID: 2970181
    [Abstract] [Full Text] [Related]

  • 18. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R, Ferri C, Bellini C, Desideri G, De Angelis C, Santucci A.
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [Abstract] [Full Text] [Related]

  • 19. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T, Heim JM, Weil J, Wehling M, Witzgall H, Gerzer R.
    J Cardiovasc Pharmacol; 1987 Feb; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [Abstract] [Full Text] [Related]

  • 20. Prolonged low dose infusion of atrial natriuretic factor in essential hypertension.
    Cusson JR, Thibault G, Cantin M, Larochelle P.
    Clin Exp Hypertens A; 1990 Feb; 12(1):111-35. PubMed ID: 2155074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.